Sonora Investment Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Sonora Investment Management’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$10K	Sell	53 -50	-49%	-$9.76K	﹤0.01%	791
2021 Q2	$21K	Buy	103 +5	+5%	+$1.05K	﹤0.01%	568
2021 Q1	$21K	Sell	98 -5	-5%	-$1.1K	﹤0.01%	969
2020 Q4	$24K	Hold	103	–	–	﹤0.01%	850
2020 Q3	$28K	Hold	103	–	–	﹤0.01%	740
2020 Q2	$30K	Sell	103 -81	-44%	-$22K	﹤0.01%	633
2020 Q1	$44K	Buy	184 +5	+3%	+$1.15K	0.01%	533
2019 Q4	$39K	Buy	179 +81	+83%	+$16.4K	﹤0.01%	632
2019 Q3	$17K	Hold	98	–	–	﹤0.01%	944
2019 Q2	$18K	Hold	98	–	–	﹤0.01%	925
2019 Q1	$18K	Hold	98	–	–	﹤0.01%	836
2018 Q4	$16K	Buy	98 +50	+104%	+$8.66K	﹤0.01%	707
2018 Q3	$9K	Hold	48	–	–	﹤0.01%	928
2018 Q2	$8K	Hold	48	–	–	﹤0.01%	884
2018 Q1	$7.82K	Hold	48	–	–	﹤0.01%	859
2017 Q4	$7.19K	Hold	48	–	–	﹤0.01%	893
2017 Q3	$7.3K	Buy	48 +28	+140%	+$4.21K	﹤0.01%	801
2017 Q2	$2.58K	Hold	20	–	–	﹤0.01%	888
2017 Q1	$2.19K	Hold	20	–	–	﹤0.01%	853
2016 Q4	$1.47K	Hold	20	–	–	﹤0.01%	786
2016 Q3	$1.74K	Hold	20	–	–	﹤0.01%	763
2016 Q2	$1.72K	Hold	20	–	–	﹤0.01%	787
2016 Q1	$1.71K	Hold	20	–	–	﹤0.01%	860
2015 Q4	$3K	Sell	20 -58	-74%	-$7K	﹤0.01%	692
2015 Q3	$10K	Buy	+78	New	+$10K	﹤0.01%	499

Other funds holding VRTX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sonora Investment Management's VRTX Position: Q3 2021 in Review

Sonora Investment Management reduced its Vertex Pharmaceuticals (VRTX) stake by 49% in Q3 2021, selling an estimated $9.76K and leaving 53 shares worth $10K. The position accounts for ﹤0.01% of the portfolio, ranked #791.

Sonora Investment Management first reported a position in VRTX in Q3 2015 and has held it in 25 quarters since. The position peaked at $44K in Q1 2020. 934 funds tracked by Wall St. Rank hold VRTX as of Q3 2021.

Sonora Investment Management held 53 shares of Vertex Pharmaceuticals worth $10K as of Q3 2021.
Sonora Investment Management sold 50 Vertex Pharmaceuticals shares in Q3 2021, an estimated $9.76K.
Vertex Pharmaceuticals made up ﹤0.01% of Sonora Investment Management's portfolio in Q3 2021, its #791 holding.
Sonora Investment Management first reported a position in Vertex Pharmaceuticals in Q3 2015 and has held it in 25 quarters since.
Sonora Investment Management's Vertex Pharmaceuticals position peaked at $44K in Q1 2020.
934 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2021.

Based on Sonora Investment Management's 13F filing for Q3 2021, filed 12 Nov 2021.